Favorable response to trastuzumab plus irinotecan combination therapy in two patients with HER2-positive relapsed small-cell lung cancer (Q27853123)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Favorable response to trastuzumab plus irinotecan combination therapy in two patients with HER2-positive relapsed small-cell lung cancer
scientific article

    Statements

    Favorable response to trastuzumab plus irinotecan combination therapy in two patients with HER2-positive relapsed small-cell lung cancer (English)
    1 reference
    Yuhei Kinehara
    0 references
    Toshiyuki Minami
    0 references
    Takashi Kijima
    0 references
    Shigenori Hoshino
    0 references
    Osamu Morimura
    0 references
    Tomoyuki Otsuka
    0 references
    Yoshitomo Hayama
    0 references
    Kiyoharu Fukushima
    0 references
    Yoshiko Takeuchi
    0 references
    Masayoshi Higashiguchi
    0 references
    Kotaro Miyake
    0 references
    Haruhiko Hirata
    0 references
    Izumi Nagatomo
    0 references
    Koji Inoue
    0 references
    Yoshito Takeda
    0 references
    Hiroshi Kida
    0 references
    Atsushi Kumanogoh
    0 references
    March 2015
    0 references
    0 references
    87
    0 references
    3
    0 references
    321-5
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit